MiR-340 targets SPP1 to inhibit the PI3K/AKT pathway, and activates the Snail/Slug signaling pathway, further inhibiting the proliferation, migration, invasion and EMT of gastric cancer cells (Song et al., 2019a; Chen et al., 2019). This evidence concerns the gene AKT1 and gastric cancer.